Patents Assigned to LIOR CARMON
  • Antigen specific multi epitope-based anti-infective vaccines
    Patent number: 10350284
    Abstract: The invention provides peptide vaccines comprising the signal peptide domain of selected target antigens of intracellular pathogens. The peptide vaccines of the invention contain multiple class II and class I-restricted epitopes and are recognized and presented by the majority of the vaccinated human population. The invention provides in particular anti tuberculosis vaccines. The invention further provides compositions comprising the vaccines as well as their use to treat or prevent infection.
    Type: Grant
    Filed: March 31, 2019
    Date of Patent: July 16, 2019
    Assignees: Lior Carmon, VAXIL BIOTHERAPEUTICS LTD.
    Inventor: Lior Carmon
  • Antigen specific multi epitope-based anti-infective vaccines
    Patent number: 9642903
    Abstract: Provided are peptide vaccines including the signal peptide domain of selected target antigens of intracellular pathogens. The peptide vaccines of the invention contain multiple class II and class I-restricted epitopes and are recognized and presented by the majority of the vaccinated human population. Further provided, in particular, are anti tuberculosis vaccines. Also further provided are compositions including the vaccines as well as their use to treat or prevent infection.
    Type: Grant
    Filed: July 15, 2010
    Date of Patent: May 9, 2017
    Assignees: LIOR CARMON, VAXIL BIOTHERAPEUTICS LTD.
    Inventor: Lior Carmon